Consent Forms

2

Review clinical trials related to Consent Forms. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Effectiveness of Large Language Model for Anaesthesia and Procedural Consent

Patient understanding of anaesthesia risks remains inconsistent due to time constraints, language barriers, and variable clinician communication styles. Traditional verbal consent may not consistently ensure comprehension or reduce preoperative anxiety. PEAR (Patient Education of Anesthesia Risks) is a multilingual, AI-driven chatbot developed to enhance patient education and improve the quality of anaesthesia risk counselling. Study Objective: To compare PEAR's performance in delivering anaesthesia risk consent against the standard face-to-face verbal method.

Participants needed: 120
Trial details
Age: 21-99Biological sex: AllType: InterventionalSponsor: Singapore General HospitalUpdated: May 7, 2026Locations: 2
Eligibility criteria

Able to provide informed consent [+2]

ASA Physical Status IV or above [+4]

Status: Recruiting

Post-market Clinical Follow-up Study of NEMOST V2

The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children. As part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth domino. Retrospective and prospective multicenter post-market surveillance clinical study. This study is interventional, non-randomized, and uncontrolled. The primary objective of this clinical study is to monitor complications related to the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children. The secondary objective of this clinical study is to monitor the performance of the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children. The study will include 140 patients.

Participants needed: 140
Trial details
Age: 5-17Biological sex: AllType: InterventionalSponsor: EUROSUpdated: Feb 11, 2026Locations: 5
Eligibility criteria

Idiopathic, congenital, neuromuscular, or syndromic scoliosis : Progressive spin... [+2]

signs of local inflammation; [+5]